Annual Retained Earnings
-$1.77 B
-$177.12 M-11.14%
31 December 2023
Summary:
Lexicon Pharmaceuticals annual retained earnings is currently -$1.77 billion, with the most recent change of -$177.12 million (-11.14%) on 31 December 2023. During the last 3 years, it has fallen by -$366.82 million (-26.20%). LXRX annual retained earnings is now -6011.73% below its all-time high of -$28.91 million, reached on 31 December 1999.LXRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.93 B
-$64.81 M-3.47%
30 September 2024
Summary:
Lexicon Pharmaceuticals quarterly retained earnings is currently -$1.93 billion, with the most recent change of -$64.81 million (-3.47%) on 30 September 2024. Over the past year, it has dropped by -$216.39 million (-12.60%). LXRX quarterly retained earnings is now -4467.98% below its all-time high of -$42.33 million, reached on 31 March 2000.LXRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.1% | -12.6% |
| 3 y3 years | -26.2% | -32.2% |
| 5 y5 years | -20.1% | -49.9% |
LXRX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -26.2% | at low | -32.2% | at low |
| 5 y | 5 years | -31.7% | at low | -49.9% | at low |
| alltime | all time | -6011.7% | at low | -4468.0% | at low |
Lexicon Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.93 B(+3.5%) |
| June 2024 | - | -$1.87 B(+2.9%) |
| Mar 2024 | - | -$1.82 B(+2.7%) |
| Dec 2023 | -$1.77 B(+11.1%) | -$1.77 B(+2.9%) |
| Sept 2023 | - | -$1.72 B(+3.0%) |
| June 2023 | - | -$1.67 B(+2.8%) |
| Mar 2023 | - | -$1.62 B(+2.0%) |
| Dec 2022 | -$1.59 B(+6.9%) | -$1.59 B(+2.0%) |
| Sept 2022 | - | -$1.56 B(+1.5%) |
| June 2022 | - | -$1.54 B(+1.6%) |
| Mar 2022 | - | -$1.51 B(+1.6%) |
| Dec 2021 | -$1.49 B(+6.3%) | -$1.49 B(+1.8%) |
| Sept 2021 | - | -$1.46 B(+1.6%) |
| June 2021 | - | -$1.44 B(+1.3%) |
| Mar 2021 | - | -$1.42 B(+1.5%) |
| Dec 2020 | -$1.40 B(+4.4%) | -$1.40 B(+0.4%) |
| Sept 2020 | - | -$1.39 B(-5.6%) |
| June 2020 | - | -$1.48 B(+4.9%) |
| Mar 2020 | - | -$1.41 B(+5.0%) |
| Dec 2019 | -$1.34 B(-8.8%) | -$1.34 B(+4.0%) |
| Sept 2019 | - | -$1.29 B(-14.9%) |
| June 2019 | - | -$1.52 B(+1.5%) |
| Mar 2019 | - | -$1.49 B(+1.5%) |
| Dec 2018 | -$1.47 B(+7.8%) | -$1.47 B(+0.0%) |
| Sept 2018 | - | -$1.47 B(+1.9%) |
| June 2018 | - | -$1.44 B(+2.5%) |
| Mar 2018 | - | -$1.41 B(+3.2%) |
| Dec 2017 | -$1.37 B(+9.2%) | -$1.37 B(+0.9%) |
| Sept 2017 | - | -$1.35 B(+2.3%) |
| June 2017 | - | -$1.32 B(+2.7%) |
| Mar 2017 | - | -$1.29 B(+2.9%) |
| Dec 2016 | -$1.25 B(+12.8%) | -$1.25 B(+2.7%) |
| Sept 2016 | - | -$1.22 B(+3.0%) |
| June 2016 | - | -$1.18 B(+3.3%) |
| Mar 2016 | - | -$1.14 B(+3.1%) |
| Dec 2015 | -$1.11 B(+0.4%) | -$1.11 B(-7.3%) |
| Sept 2015 | - | -$1.20 B(+3.0%) |
| June 2015 | - | -$1.16 B(+2.5%) |
| Mar 2015 | - | -$1.13 B(+2.5%) |
| Dec 2014 | -$1.10 B(+10.0%) | -$1.10 B(+0.3%) |
| Sept 2014 | - | -$1.10 B(+3.8%) |
| June 2014 | - | -$1.06 B(+2.5%) |
| Mar 2014 | - | -$1.03 B(+3.1%) |
| Dec 2013 | -$1.00 B(+11.6%) | -$1.00 B(+1.8%) |
| Sept 2013 | - | -$986.54 M(+3.3%) |
| June 2013 | - | -$954.89 M(+3.1%) |
| Mar 2013 | - | -$925.81 M(+2.9%) |
| Dec 2012 | -$899.83 M | -$899.83 M(+2.8%) |
| Sept 2012 | - | -$874.96 M(+3.5%) |
| June 2012 | - | -$845.42 M(+3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | -$819.49 M(+3.8%) |
| Dec 2011 | -$789.62 M(+17.3%) | -$789.62 M(+4.5%) |
| Sept 2011 | - | -$755.78 M(+3.6%) |
| June 2011 | - | -$729.67 M(+3.8%) |
| Mar 2011 | - | -$703.03 M(+4.4%) |
| Dec 2010 | -$673.41 M(+18.1%) | -$673.41 M(+3.5%) |
| Sept 2010 | - | -$650.41 M(+4.4%) |
| June 2010 | - | -$622.89 M(+4.2%) |
| Mar 2010 | - | -$597.70 M(+4.8%) |
| Dec 2009 | -$570.17 M(+17.0%) | -$570.17 M(+4.0%) |
| Sept 2009 | - | -$548.17 M(+3.6%) |
| June 2009 | - | -$529.03 M(+3.9%) |
| Mar 2009 | - | -$508.95 M(+4.4%) |
| Dec 2008 | -$487.39 M(+18.7%) | -$487.39 M(+3.3%) |
| Sept 2008 | - | -$471.98 M(+5.2%) |
| June 2008 | - | -$448.52 M(+4.7%) |
| Mar 2008 | - | -$428.49 M(+4.4%) |
| Dec 2007 | -$410.54 M(+16.7%) | -$410.54 M(+3.1%) |
| Sept 2007 | - | -$398.36 M(+3.7%) |
| June 2007 | - | -$384.25 M(+3.7%) |
| Mar 2007 | - | -$370.66 M(+5.4%) |
| Dec 2006 | -$351.74 M(+18.3%) | -$351.74 M(+4.1%) |
| Sept 2006 | - | -$337.92 M(+3.9%) |
| June 2006 | - | -$325.16 M(+5.5%) |
| Mar 2006 | - | -$308.26 M(+3.6%) |
| Dec 2005 | -$297.43 M(+13.9%) | -$297.43 M(-1.9%) |
| Sept 2005 | - | -$303.34 M(+4.9%) |
| June 2005 | - | -$289.22 M(+5.4%) |
| Mar 2005 | - | -$274.38 M(+5.1%) |
| Dec 2004 | -$261.12 M(+22.0%) | -$261.12 M(+0.2%) |
| Sept 2004 | - | -$260.57 M(+5.8%) |
| June 2004 | - | -$246.20 M(+7.3%) |
| Mar 2004 | - | -$229.41 M(+7.2%) |
| Dec 2003 | -$213.94 M(+42.9%) | -$213.94 M(+7.5%) |
| Sept 2003 | - | -$199.07 M(+7.9%) |
| June 2003 | - | -$184.51 M(+10.6%) |
| Mar 2003 | - | -$166.89 M(+11.4%) |
| Dec 2002 | -$149.75 M(+66.2%) | -$149.75 M(+10.2%) |
| Sept 2002 | - | -$135.88 M(+14.1%) |
| June 2002 | - | -$119.07 M(+14.3%) |
| Mar 2002 | - | -$104.13 M(+15.6%) |
| Dec 2001 | -$90.08 M(+64.1%) | -$90.08 M(+13.9%) |
| Sept 2001 | - | -$79.07 M(+8.5%) |
| June 2001 | - | -$72.85 M(+15.8%) |
| Mar 2001 | - | -$62.91 M(+14.6%) |
| Dec 2000 | -$54.90 M(+89.9%) | -$54.90 M(+15.9%) |
| Sept 2000 | - | -$47.38 M(+3.4%) |
| June 2000 | - | -$45.84 M(+8.3%) |
| Mar 2000 | - | -$42.33 M |
| Dec 1999 | -$28.91 M | - |
FAQ
- What is Lexicon Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual retained earnings year-on-year change?
- What is Lexicon Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly retained earnings year-on-year change?
What is Lexicon Pharmaceuticals annual retained earnings?
The current annual retained earnings of LXRX is -$1.77 B
What is the all time high annual retained earnings for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual retained earnings is -$28.91 M
What is Lexicon Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, LXRX annual retained earnings has changed by -$177.12 M (-11.14%)
What is Lexicon Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of LXRX is -$1.93 B
What is the all time high quarterly retained earnings for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly retained earnings is -$42.33 M
What is Lexicon Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, LXRX quarterly retained earnings has changed by -$216.39 M (-12.60%)